Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2022 Mar 21;14(2):213-219.
doi: 10.3390/idr14020026.

Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience

Affiliations

Risk Factors Associated with Poor Outcome in Patients with Infective Endocarditis: An Italian Single-Center Experience

Claudio Ucciferri et al. Infect Dis Rep. .

Abstract

Background: Nowadays, infective endocarditis (IE) is still burdened by a high mortality. In the absence of an adequate prognostic stratification system, it is important to assess new predictors of poor outcomes. The aim of our study is to evaluate which factors were associated with higher mortality in IE patients. Methods: A retrospective cohort study enrolled patients with an IE diagnosis at the Infectious Diseases Clinic of the University ‘G. D’Annunzio’, Chieti, Italy from January 2013 to December 2019. For each patient, demographic, anamnestic and clinical information, embolic phenomena, laboratory and microbiologic data, treatment, and outcomes were collected and analyzed. A correlation analysis was performed. Results: Sixty-eight patients with EI were studied; among them, the mortality was 17.6%, 20.6%, and 23.5%, intra-hospital, at 1 month from discharge and at 6 months from discharge, respectively. Mortality was significantly correlated with age, estimated glomerular filtration rate, and procalcitonin values when considering either basal values (r = 0.266, p = 0.029), or values at 48−72 h from the start of an antibiotic therapy (r = 0.222; p < 0.05), cerebral embolization for 6-month mortality (r = 0.284; p = 0.019), and inadequate antibiotic therapy (r = 0.232, p < 0.05). Conclusions: Procalcitonin values, at EI diagnosis and at 48−72 h after starting antibiotics, are prognostic factors useful for stratifying patient risk, and for setting up a personalized treatment. Of note, cerebral embolization and an inappropriate empirical treatment were associated with a higher mortality in the short- and long-term.

Keywords: embolization; in-hospital mortality; infective endocarditis; procalcitonin.

PubMed Disclaimer

Conflict of interest statement

The authors declare no conflict of interest.

Figures

Figure 1
Figure 1
Population of 68 patients with infective endocarditis divided by aetiologic agent. CoNS: coagulase-negative staphylococci; HACEK: stands for Haemophilus species, Aggregatibacter species, Cardiobacterium hominis, Eikenella corrodens, and Kingella species; BCNIE: blood-culture-negative infective endocarditis.

Similar articles

Cited by

References

    1. Bennett J., Dolin R., Blaser M. Mandell, Douglas, and Bennett’s Principles and Practice of Infectious Diseases. 9th ed. Elsevier; Amsterdam, The Netherlands: 2019.
    1. The 2015 ESC Guidelines for the management of infective endocarditis. Eur. Heart J. 2015;36:3036–3037. doi: 10.1093/eurheartj/ehv488. - DOI - PubMed
    1. Iversen K., Ihlemann N., Gill S.U., Madsen T., Elming H., Jensen K.T., Bruun N.E., Høfsten D.E., Fursted K., Christensen J.J., et al. Partial Oral versus Intravenous Antibiotic Treatment of Endocarditis. N. Engl. J. Med. 2019;380:415–424. doi: 10.1056/NEJMoa1808312. - DOI - PubMed
    1. Mancino P., Ucciferri C., Falasca K., Pizzigallo E., Vecchiet J. Methicillin-resistant Staphylococcus epidermidis (MRSE) endocarditis treated with linezolid. Scand. J. Infect. Dis. 2008;40:67–73. doi: 10.1080/00365540701509915. - DOI - PubMed
    1. Yeager S.D., Oliver J.E., Shorman M.A., Wright L.R., Veve M.P. Comparison of linezolid step-down therapy to standard parenteral therapy in methicillin-resistant Staphylococcus aureus bloodstream infections. Int. J. Antimicrob. Agents. 2021;57:106329. doi: 10.1016/j.ijantimicag.2021.106329. - DOI - PubMed

LinkOut - more resources